These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9513074

  • 1. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
    Yasutake K, Amano M, Mizokami Y, Kubota S, Fukumoto H, Imamura Y, Yokoya H, Irie K.
    J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG, de Looze SM, Bender W, Labs R.
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [Abstract] [Full Text] [Related]

  • 3. Roxatidine versus ranitidine in the treatment of duodenal ulcers: a randomized double-blind controlled multicentre study in Singapore.
    Fock KM, Kang JY, Ng HS, Ng TM, Gwee KA, Lim CC.
    J Gastroenterol Hepatol; 1995; 10(4):379-82. PubMed ID: 8527701
    [Abstract] [Full Text] [Related]

  • 4. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H, Hamada K, Aijima H, Taga F, Uchida H, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [Abstract] [Full Text] [Related]

  • 5. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U, Chinapak O, Vongphanich V, Kositchaiwat C, Lekhayananda S, Khow-ean U, Suttinont C, Saowaros V, Kludchareon N, Leethochawalit M.
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group.
    Brandstätter G, Marks IN, Lanza F, Kogut D, Cobert B, Savitsky JP, Bender W, Labs R, Wurzer H.
    Clin Ther; 1995 Dec; 17(3):467-78. PubMed ID: 7585851
    [Abstract] [Full Text] [Related]

  • 7. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
    Inoue M.
    Drugs; 1988 Dec; 35 Suppl 3():114-9. PubMed ID: 2905239
    [Abstract] [Full Text] [Related]

  • 8. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
    Amarapurkar DN, Parikh SS, Desai HG.
    J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
    [Abstract] [Full Text] [Related]

  • 9. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
    Clin Ther; 1991 Aug; 13(1):47-57. PubMed ID: 1674231
    [Abstract] [Full Text] [Related]

  • 10. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T, Hirata W, Higichi S.
    Int J Clin Pharmacol Res; 2002 Aug; 22(2):29-35. PubMed ID: 12503773
    [Abstract] [Full Text] [Related]

  • 11. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
    Hüttemann W.
    Drugs; 1988 Aug; 35 Suppl 3():90-5. PubMed ID: 2905255
    [Abstract] [Full Text] [Related]

  • 12. Famotidine in the USA: a review of efficacy studies.
    Gitnick G.
    J Int Med Res; 1989 Aug; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [Abstract] [Full Text] [Related]

  • 13. A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.
    Walt RP, Logan RF, Hawkey CJ, Daneshmend TK, Long RG, Cooper BT, Langman MJ, Collins M, Street R.
    Aliment Pharmacol Ther; 1991 Jun; 5(3):301-7. PubMed ID: 1679668
    [Abstract] [Full Text] [Related]

  • 14. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 15. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
    Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL.
    J Int Med Res; 1989 Apr; 17 Suppl 1():25A-31A. PubMed ID: 2566541
    [Abstract] [Full Text] [Related]

  • 16. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
    Judmaier G.
    Drugs; 1988 Apr; 35 Suppl 3():120-6. PubMed ID: 2905240
    [Abstract] [Full Text] [Related]

  • 17. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA, Bazarova MA, Nikitina SA, Osin VL, Shugurov VA.
    Khirurgiia (Mosk); 2001 Apr; (10):49-50. PubMed ID: 11763821
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of roxatidine and famotidine on nocturnal gastric juice secretion.
    Tanioka H, Kaga K.
    J Int Med Res; 1996 Apr; 24(1):88-91. PubMed ID: 8674804
    [Abstract] [Full Text] [Related]

  • 19. Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer: a randomized, double-masked, multicenter study.
    Zuberi SJ, Khan AQ, Irshad-ul-Haque I, Hussain A, Hasnain SS, Shah S, Sadick A, Yusuf MZ, Reuter M.
    Clin Ther; 1996 Apr; 18(6):1207-12. PubMed ID: 9001837
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of duodenal ulcer with famotidine].
    Schütze K, Hentschel E, Reichel W, Kerstan E.
    Wien Med Wochenschr; 1987 Sep 15; 137(17):409-11. PubMed ID: 2891224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.